AIT Therapeutics, Inc. (AITB) financial statements (2021 and earlier)

Company profile

Business Address 825 EAST GATE BOULEVARD, SUITE 320
GARDEN CITY, NY 11530
State of Incorp. DE
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:2226820
Cash and cash equivalents2220110
Short-term investments  71 
Other undisclosed cash, cash equivalents, and short-term investments 60  
Restricted cash and investments1600 
Receivables   0 
Deferred costs0    
Other current assets    0
Other undisclosed current assets0(4)10 
Total current assets:2327920
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment1000 
Other noncurrent assets0    
Other undisclosed noncurrent assets000  
Total noncurrent assets:2110 
TOTAL ASSETS:2527920
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities33310
Accounts payable12110
Accrued liabilities112 0
Deferred revenue01
Debt 00 0
Due to related parties 000 
Other liabilities    0
Other undisclosed current liabilities002  
Total current liabilities:35510
Noncurrent Liabilities
Long-term debt and lease obligation54   
Long-term debt, excluding current maturities44   
Operating lease, liability00
Liabilities, other than long-term debt   9 
Derivative instruments and hedges, liabilities   9 
Other undisclosed noncurrent liabilities(0)(0)   
Total noncurrent liabilities:54 9 
Total liabilities:895110
Stockholders' equity
Stockholders' equity attributable to parent17184(8)(0)
Common stock00000
Treasury stock, value(0)(0)(0)(0) 
Additional paid in capital927642230
Accumulated other comprehensive income   0 
Accumulated deficit(75)(58)(38)(32)(0)
Total stockholders' equity:17184(8)(0)
TOTAL LIABILITIES AND EQUITY:2527920

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
12/31/2017
12/31/2016
Gross profit:218  
Operating expenses(23)(12)(11)(11)(0)
Other undisclosed operating loss(21)(8)   
Operating loss:(42)(18)(3)(11)(0)
Nonoperating expense(2)(2)(3)(0) 
Other nonoperating expense  (0)(0) 
Interest and debt expense(0)(0) (0)(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)  (7) 
Loss from continuing operations before equity method investments, income taxes:(45)(20)(7)(18)(0)
Other undisclosed income from continuing operations before income taxes00   
Loss from continuing operations before income taxes:(45)(20)(7)(18)(0)
Income tax expense (0)   
Other undisclosed loss from continuing operations(0)    
Net loss:(45)(20)(7)(18)(0)
Other undisclosed net income (loss) attributable to parent140  (0)
Net loss attributable to parent:(31)(20)(7)(18)(0)
Other undisclosed net income available to common stockholders, basic4040   
Net income (loss) available to common stockholders, diluted:920(7)(18)(0)

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
12/31/2017
12/31/2016
Net loss:(45)(20)(7)(18)(0)
Comprehensive loss:(45)(20)(7)(18)(0)
Other undisclosed comprehensive income, net of tax, attributable to parent13  0 
Comprehensive loss, net of tax, attributable to parent:(32)(20)(7)(18)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: